ABSTRACT Statin, a 57,000-D protein characteristically found in nonreplicating cells, was identified by a monoclonal antibody produced by hybridomas established from mice injected with extracts of in vitro aged human fibroblasts (Wang, E., 1985, J. Cell Biol., 100:545-551).
Studies to distinguish proliferating cells from their nonproliferating counterparts were limited to a description of phenotypic characteristics until the recent development of powerful probes, such as cDNA clones and monoclonal antibodies. Lately, a growing number of new proteins have been identified in cells at particular stages of development or differentiation by the use of unique monoclonal antibodies (3, 7, 8) . With a similar approach, several novel proteins found only in proliferating or in nonproliferating cells have been localized either on the cell surface or in the nucleus (2, 6, 11) .
We reported earlier that a protein of 57,000 D is present in the nucleus of nonproliferating cells from several lines of in vitro aged human fibroblasts, but not in their proliferating counterparts (11) . However, the presence of this nuclear antigen was not restricted to senescent fibroblasts; young fibroblasts can be induced to express it upon the arrest of proliferation such as culturing to confluency. The nuclear presence of this protein also is characteristic of many tissue sites composed of nonproliferating cells (12) . The absence of this protein is noted in tissues, such as epithelium of the gastrointestinal tract and kidney and the basal layer of the epidermis, where ceils are replicating.
We now report that the expression of statin can be rapidly turned off once the restriction of cell replication at Go/G~ is removed. The deactivation of statin expression is heterogeneous among different cells but, in general, occurs before the actual event of mitosis. Therefore, the expression of statin seems to be incompatible with the mechanism that promotes cell cycling events.
MATERIALS AND METHODS

Cultures of Human Fibroblasts
Two cell strains of human fibroblasts were obtained from the Human Genetic Cell Repository (Camden, N J). These cell strains were initiated by Abbreviation used in this paper. PDLs, population doubling levels.
THE JOURNAL OF CELL BIOLOGY • VOLUME 101 NOVEMBER 1985 1695 1701 culturing skin biopsies derived from two different donors. Reference number 0011 was designated for the fibroblast cultures derived from a donor of 8 fetal wk, and 3529 for cultures derived from another donor 66-yr-old. The complete in vitro life spans of these two cell strains have been established in our laboratory and reported ( 11 ) . Cultures of varied life spans as represented by population doubling levels (PDLs) ~ were acquired by serial passage as described (4, 11) . Eagle's minimum essential medium supplemented with 10% fetal calf serum and 1% nonessential amino acid was used for growth and maintenance of cultures at 37"C with humidified air and 5% CO2.
Antibodies
A mouse hybridoma clone S-30 was identified to produce an antibody that detects a protein of 57,000 D present in abundance only in nonproliferating cells. This hybridoma clone was established by injecting a mouse with insoluble cellular materials derived from the senescent fibroblasts of the 3529 cell strain. A detailed description of the antigenic activity was reported previously (11) . The quality of monoclonal antibody was improved by generating a serum-free supernatant of clone S-30 cultures. After precipitation with ammonium sulfate, the secreted immunoglobulin (IgG) was concentrated 100-fold and used as the stock solution for various immunoassays of the present study.
Reinitiation of Proliferating Activity
IN VITRO WOUNDING EXPERIMENTS: Young fibroblasts with high replicating activity at an early stage of their life span were grown into confluency to halt the activity of proliferation. Growing cultures of both 3529 and 0011 cell strains at PDLs less than 15 were used. Cultures were initiated at a density of 3,550 cells/cm 2, and confluency was reached as cells grew to ten times this density ~7 d after initial plating. These cultures were kept in this confluent state for another 3 d before use. The absence of proliferating activity was monitored by time-lapse cinematography showing little mitotic activity, and by quantitation of DNA content by flow cytometry (see below). Denudation of an area of -2 × 4 cm 2 was introduced into these confluent cultures by sterile razor blades.
TRYPSINIZATION AND REPLATING:
The same type of confluent culture as described above was used for reinitiation of cell replication by subculturing at lower growth density. Cells were dislodged from the confluent monolayer by treatment with trypsin at 0.5%, and replated into the growth medium at a density of 1,770 cells/cm 2. Mitosis was reinitiated and examined by kinetic studies at various time intervals after the seeding of the fibroblasts.
Time-Lapse Cinematography
The mitotic frequency in cultures of nonreplieating cells, as well as fibroblasts with reinitiated replicating activity, was investigated by cinematographic studies using a time-lapse video recording device. Cultures were filmed directly on a Nikon Diaphot inverted microscope with 6x phase optics (Nikon Inc., Garden City, NY). The temperature of the environment immediately surrounding the culture was maintained at 37"C by a Sage air incubator (Sage Instruments Div., Cambridge, MA). Cell locomotion as well as the actual events of cell division were recorded on Beta-max videotape by a National Electrostatics Corp. (Middleton, WI) time-lapse videotape recorder. The recorded tape was then analyzed on a regular Audiotronics monitor (Audiotronic, Inc., North Hollywood, CA). Experiments for cinematographic studies were designed in parallel to those cell specimens used for various immunoassays. These parallel experiments allow us to compare the expression of statin in various cell cultures with mitotic frequency.
Immunofluorescence and Immunoelectron Microscopy
Presence of statin was identified at the light microscopic level by labeling the formaldehyde-fixed and acetone-extracted cell specimens with the mouse monoclonal antibody, S-30. Fluoresceinated secondary antibody, goat antimouse immunoglobulin, was used to localize the binding sites of S-30 lgGs. The details of the labeling procedure have been reported (l 1). To identify the ultrastructural location of S-30 binding sites, we have used the technique of immunogold labeling (5), In brief, cell specimens were prepared by formaldehyde fixation, followed by extraction with 0.5% Triton in phosphate-buffered saline (PBS), at pH 7.2. These specimens were then labeled with the antibody to statin, followed by labeling with protein A conjugated with 5-nm colloidal gold particles as described (14) . Afterwards, the samples were processed for routine electron microscopy (13).
Immunoblotting Analysis
Fibroblasts of confluent cultures of the 0011 strain as described above were processed to obtain cellular materials of nonreplicating cells. Cells were harvested in PBS and pelleted by low speed centrifugation ( 1,000 rpm for 10 min). The cell pellets were then homogenized and lysed with a dounce homogenizer in lysis buffer containing 20 mM Tris, 10 mM KCI, 5 mM MgCI2, 0.1 mM phenylmethylsulfonyl fluoride, 4 mM EDTA, and 2 mM EGTA. The cell lysate was treated with deoxyribonuclease I (DNase I) for 30 min at 4"C to remove the DNA, followed by tip-sonication to dissociate the insoluble cytoskeletal materials. Cellular proteins were then separated electrophoretically on 10% polyacrylamide gels. Replicating fibroblasts of a sparse culture, with only 2% of cells showing staining activity for statin, were processed in the same fashion for gel electrophoresis. The same amount of protein specimens for both nonreplicating and replicating fibroblasts were used for gel electrophoresis. Proteins were then transferred to nitrocellulose paper in a Hoefer Trans-blot chamber (Hoefer Scientific Instruments, San Francisco, CA), as described (9) . Normal goat serum at 0.05 ug/ml was used to remove nonspecific activity before incubation overnight with the primary S-30 antibody at 1:500 dilution in PBS containing 0.03% Tween-20. The second antibody was peroxidaseconjugated goat anti-mouse lgG (HyClone Laboratories, Logan, UT) at 0.04 ug/ml for incubation at room temperature for 1 h. The detailed procedure has been reported (10) .
Simultaneous Examination of Cell Cycle Analysis and Statin Expression
The newly developed technique of flow cytometry was used to examine statin expression via antibody staining and the distribution of cell cycle phases by DNA content (1) . The detailed procedure of simultaneous measurements of DNA quantity and the fluorescent intensity for antibody labeling of cellular antigens was recently described (15) . In brief, the DNA content was measured by staining intensity with propidium iodide, which can be detected by a band of 600-650-nm wavelength for red fluorescence. The statin expression is measured by the band of 515-575-nm wavelength to detect the green fluorescence of fluorescein isothiocyanate-labeled secondary antibody. A third parameter, red pulse width determined by nuclear diameter, was used to discriminate single cells from cell aggregates. Cells were initially prepared for indirect immunofluorescence microscopy, and after treatment with RNase were counterstained with propidium iodide for DNA content. The measurements ofstatin expression and cell cycle distribution were performed on the Cytofluorograf FC200 (Ortho Diagnostic Instruments, Westwood, MA) with the generous assistance of the laboratory of Dr. Andreeff of Memorial Sloan-Kettering Cancer Center, New York.
RESULTS
In vitro wounding was the first approach to reinitiate cell cycling activity in confluent cultures of nonreplicating fibroblasts. In general, a time span of 6 h was needed for the culture to recover from the mechanical shock incurred during the wounding. Subsequently, cells migrated into the wounded area by forming fan-shaped leading edges. A second approach to reinitiate replicating activity involved passing the confluent cultures to lower cell density. The (Figs. 2, E and F) . At 24 h after replating, close to 90% of the cell monolayer shows negative staining activity for antibody to statin (Figs. 2, G and H). Time-lapse cinematographic studies show that the culture at this point begins to show noticeable mitotic activity.
Quantitation of the statin loss in post-trypsinized cultures was made by direct examination of fluorescent staining activity, counting ~500 cells of the specimens; the results are shown in Fig. 3 . For the initial 4 h after release from the contact arrest of growth, >80% of the cells still retain statin expression. At 12 h, the loss of statin expression reaches to 50% of the cell cultures. At 24 h, the loss of nuclear staining reaches its peak as -80% of the flbroblasts show negative antigenic reaction to statin.
Immunogold labeling with high-titred antibody showed that statin is primarily located at the nuclear envelope in nonproliferating fibroblasts of confluent cultures (Fig. 4 a) . Statin is distributed along the entire nuclear envelope, as indicated by the positioning of gold particles. A few gold particles were seen associated with the nucleoplasm as well as adjacent intermediate filaments on the cytoplasmic side. This is possibly due to nonspecific background staining, since the same type of gold labeling was observed in control specimens when the primary antibody was replaced with a monoclonal antibody to neurofilaments (which are not found in human flbroblasts). As shown in Fig. 4b , the nuclear envelopespecific labeling was not observed when anti-statin IgGs were incubated with replicating fibroblasts, when the restriction of growth by confluency was removed.
To determine that the absence of nuclear staining seen by fluorescence microscopy is indeed the absence of statin, we have subjected the insoluble protein extracts from the nonreplicating fibroblasts of the confluent cultures to gel electrophoresis, followed by transfer to nitrocellulose paper. When the paper was incubated with S-30 monoclonal antibody, the 57,000-D protein and the accompanying high molecular weight doublets were recognized (Fig. 5, lane B) . In contrast, the antibody did not react with the protein extracts derived from the replicating fibroblasts of the same specimens used for the experiments of Fig. 2 , G and H (Fig. 5, lane C) . Fig. 6 demonstrates the cell cycle distribution and intensity of statin expression in nonreplicating flbroblasts of confluent cultures, and in the replicating flbroblasts that have been released from the restraint of density arrest by subculturing. As shown in A, the majority of cells among the nonreplicating fibroblasts, showing positive staining for statin, are the same group of cells whose growth is arrested at the Go/G~ phase of the cell cycle. This close correlation was lost rapidly when the cells were released from the confluent state. The number of cells exhibiting positive staining reaction, as well as the fluorescent intensity of those positive cells, are significantly reduced (Fig. 6 B) . By the analysis of DNA content, fibroblasts are distributed in all stages of the cell cycle, including Go/G~, S, and G2 phases. Simultaneous examination of the activity of antibody staining shows that regardless of which stage of the cell cycle the cells are at, the majority of these replicating flbroblasts ofpost-trypsinized cultures contain very little statin expression.
D I S C U S S I O N
Statin, a protein of 57,000 D, was initially described to be present only in nonreplicating and senescent flbroblasts (l 1). Here, I report that the expression ofstatin in young fibroblasts of confluent culture can disappear rapidly once the cells are released from the environment of density-dependent arrest of growth. In cells reentering the cycling process, the disappearance of a statin-positive phenotype usually precedes the actual mitosis. The timing for the loss of statin is heterogeneous among different cells. Our preliminary results of serumstarved nonreplicating cells show that statin is present in them too, and upon restoration of serum to the normal growth strength (10%), the expression of statin disappears in the same time scale as described for wounded and post-trypsinized FIGURE 4 Localization of statin at the region of the nuclear envelope in nonproliferating fibroblasts of confluent cultures of 0011 cell strain (a). The absence of statin, as seen by the lack of cellbound gold particles, was found in cells whose proliferating activity was reinitiated (b). The exact procedure for the immunogold labeling technique was described in Materials and Methods. As shown in a, most of the gold particles, reflecting the locations of statin, are localized at the nuclear envelope region as indicated by the arrowheads. A small proportion of gold particles is found in the nuclear matrix region (N). The association of gold particles with the intermediate filaments on the cytoplasmic side is regarded as nonspecific, as the same degree of binding was observed with monoclonal antibody to neurofilaments (data not shown). The absence of statin, as reflected by the lack of gold particles at the nuclear envelope region, is apparent in the replicating fibroblasts (b). Again, a small number of gold particles associated with the cytoskeleton is observed in this specimen {b). x 100,000.
cultures (data not shown).
Analysis by flow cytometry shows that those nonreplicating cells showing high statin expression in confluent cultures are indeed at the Go/G] stage of the cell cycle. Once cell replication is reinitiated, the rapid disappearance of statin is associ-ated with the shift of cells from the Go/G~ block to other phases of the cell cycle. The advantage of using the technique of flow cytometry was appreciated not only for the possibility FIGURE 5 Biochemical analysis of the disappearance of statin after the reinitiation of cell proliferation. Lane A shows the electrophoretie mobility of protein standards at 150, 92, and 58 kD. Lane B shows the presence of a protein at 57,000 D and two high molecular weight bands by immunoblotting technique when the statin antibody is incubated with specimens derived from the nonreplicating fibroblasts as in Fig. 3 a. The absence of recognizable protein bands is noticed in lane C when the same antibody at the identical IgG concentration is incubated with cell extracts from replicating fibroblasts as in Fig. 3 b. The same protein concentration was used for gel electrophoresis for both lanes B and C. This was performed by applying the same optical density units at 280 to the two gel lanes. The efficiency of protein transfer to nitrocellulose paper from the two polyacry/amide gel lanes was controlled by blotting simultaneously in the same run at 150 mA for 12 h at room temperature.
of simultaneous examination of DNA content and antibody staining for statin, but also for the ability to perform the survey with large cell samples.
In post-trypsinized cultures such as those of Fig. 2 , G and H, one can usually observe 5-10% of cells displaying the fluorescence positive staining for statin. However, we cannot detect the same degree of protein presence with the immunoblotting technique. This difference may result from the fact that specimens used for protein identifcation are pooled materials, whereas the microscopic visualization indicates the staining activity in single cells. Another possibility could result from the difference of sensitivity between immunoperoxidase, used for the blotting procedure, and fluorescence used for the microscopic studies.
In the nonreplicating fibroblasts, statin is primarily located at the region of the nuclear envelope. This is different from our previous report demonstrating that the S-30 antigenic activity is present in the entire nuclear region including the nuclear envelope (11) . The difference of immunogold localization may indeed reflect the quantitative difference ofstatin expression between contact-inhibited nonreplicating young fibroblasts and nonproliferating senescent fibroblasts. We have noticed repeatedly that former cells show less fluorescence staining activity than do senescent fibroblasts. This quantitative variation is being studied by the technique of cytofluorometry, where a large number of cells (>5,000) from different cultures can be readily analyzed.
Another difference between the nonreplicating young and senescent fibroblasts is the mere fact of reversibility for cell cycling events in the former but not in the latter (except by strenuous means of in vitro cell transformation). We do not know whether, assuming the protein is functionally related to the traverse of the cell cycle, there is a threshold of statin expression determining the irreversibility of replicating ability for fibroblasts. Do the cells at the terminal stage of their life span contain too much statin to return to the replicative pattern?
Recently, a few reports have described the presence of a protein of 36,000 D in replicating cells but not in nonreplieating counterparts (3, 7, 8, 16, 17) . The protein, originally identified by the sera of some patients with systemic lupus erythematosus, detects a nuclear antigen of cells with high replicating activity. Since then a wide variety of cell types, including many permanent cultures of transformed lines, have been verified to contain this protein, termed either as proliferating cell nuclear antigen or cyclin. It is interesting to note that, during the cell cycle, the expression of statin is inversely related to that of cyclin. We have found through preliminary observations that the two proteins, statin and cyclin, are alternatively expressed during the transition from nonreplicating to replicating state or vice versa. Most probably, statin represents a novel group of proteins present only in cells that are not proliferating, whereas cyclin is a type of protein expressed only in proliferating cells. The most important task now is to understand whether the expression of statin is the cause or the effect associated with G0/GI arrest of cell replication. We are attempting in vivo studies such as microinjection into nonreplicating or replicating cells with powerful probes such as purified statin, and ultimately the corresponding genes and antibody. Examination of various phenotypes such as mitotic events and DNA synthesis in the injected cells may provide promising leads in the various functional investigations.
